Company / Income Tax
Aquestive Therapeutics, Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2025
5-year range
-$14.0K / $245.0K
FY2021-FY2025
Trend
+100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $245,000 to $0 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax increased 100.0% year-over-year.
- Peak income tax was recorded in FY2023.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | +100.0% |
| FY2024 | -$14.0K | -105.7% |
| FY2023 | $245.0K | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026